Verdence Capital Advisors’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-11,270
Closed -$158K 296
2019
Q1
$158K Sell
11,270
-3,110
-22% -$40.8K 0.04% 258
2018
Q4
$149K Sell
14,380
-1,182
-8% -$17.4K 0.04% 229
2018
Q3
$266K Sell
15,562
-212,711
-93% -$3.65M 0.07% 220
2018
Q2
$4.11M Sell
228,273
-13,337
-6% -$267K 1% 24
2018
Q1
$4.23M Buy
241,610
+11,072
+5% +$231K 1.02% 23
2017
Q4
$5.3M Buy
+230,538
New +$4.78M 1.26% 23

Other funds holding PTEN

Verdence Capital Advisors's PTEN Position: Q2 2019 in Review

Verdence Capital Advisors sold out of Patterson-UTI (PTEN) in Q2 2019, closing a stake of 11,270 shares — an estimated $158K sold.

Verdence Capital Advisors first reported a position in PTEN in Q4 2017 and held it in 6 quarters. The position peaked at $5.3M in Q4 2017. 278 funds tracked by Wall St. Rank hold PTEN as of Q2 2019.

  • Verdence Capital Advisors reported no remaining Patterson-UTI position as of Q2 2019 after selling out during the quarter.
  • Verdence Capital Advisors sold 11,270 Patterson-UTI shares in Q2 2019, an estimated $158K.
  • Verdence Capital Advisors first reported a position in Patterson-UTI in Q4 2017 and held it in 6 quarters.
  • Verdence Capital Advisors's Patterson-UTI position peaked at $5.3M in Q4 2017.
  • 278 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2019.

Based on Verdence Capital Advisors's 13F filing for Q2 2019, filed 2 Mar 2020.